|
PGRMC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.44080003272995E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.60711460700713E-13 |
| Normal-vs-Stage2 |
4.804800E-03 |
| Normal-vs-Stage3 |
1.522400E-01 |
| Normal-vs-Stage4 |
2.242800E-01 |
| Stage1-vs-Stage2 |
6.587000E-01 |
| Stage1-vs-Stage3 |
6.775700E-04 |
| Stage1-vs-Stage4 |
1.234540E-04 |
| Stage2-vs-Stage3 |
7.937700E-02 |
| Stage2-vs-Stage4 |
5.278000E-02 |
| Stage3-vs-Stage4 |
7.949000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.48269976693894E-10 |
| Normal-vs-AfricanAmerican |
7.817200E-01 |
| Normal-vs-Asian |
8.081600E-01 |
| Caucasian-vs-AfricanAmerican |
1.038100E-04 |
| Caucasian-vs-Asian |
2.794400E-01 |
| AfricanAmerican-vs-Asian |
9.671400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.00009999462969E-08 |
| Normal-vs-Female |
2.09009999999621E-05 |
| Male-vs-Female |
6.301400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.169200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.33519999945264E-07 |
| Normal-vs-Age(61-80Yrs) |
2.45889999994642E-06 |
| Normal-vs-Age(81-100Yrs) |
6.986400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.107640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.804580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.865200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.835800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.937600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.138400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.784600E-03 |
| Normal-vs-Grade 2 |
4.32189950494433E-10 |
| Normal-vs-Grade 3 |
3.5211000000035E-05 |
| Normal-vs-Grade 4 |
3.744600E-01 |
| Grade 1-vs-Grade 2 |
7.533400E-01 |
| Grade 1-vs-Grade 3 |
2.754200E-01 |
| Grade 1-vs-Grade 4 |
7.403800E-04 |
| Grade 2-vs-Grade 3 |
2.821900E-02 |
| Grade 2-vs-Grade 4 |
7.07070002547994E-09 |
| Grade 3-vs-Grade 4 |
5.62689999999977E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.41005002013617E-12 |
| Normal-vs-ccB subtype |
1.320470E-03 |
| ccA subtype-vs-ccB subtype |
1.541530E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.28260000001423E-06 |
| Normal-vs-N1 |
9.416200E-01 |
| N0-vs-N1 |
1.761590E-01 |
|
|
